These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20065050)

  • 1. Trailing or paradoxical growth of Candida albicans when exposed to caspofungin is not associated with microsatellite genotypes.
    Khlif M; Bogreau H; Michel-Nguyen A; Ayadi A; Ranque S
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1365-8. PubMed ID: 20065050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans.
    Shields RK; Nguyen MH; Press EG; Clancy CJ
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3598-602. PubMed ID: 21537017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the paradoxical effect of caspofungin and micafungin on
    Zhouying H; Chen L; Ruiqi W; Kang L; Ji Z
    Indian J Med Microbiol; 2017; 35(2):252-255. PubMed ID: 28681815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trailing or paradoxical growth of Aspergillus flavus exposed to caspofungin is independent of genotype.
    Hadrich I; Neji S; Makni F; Ayadi A; Elloumi M; Ranque S
    J Med Microbiol; 2014 Dec; 63(Pt 12):1584-1589. PubMed ID: 25210202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of paradoxical effect with caspofungin in Candida albicans.
    Stevens DA
    Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):717. PubMed ID: 19130103
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity of White and Opaque Candida albicans Cells to Antifungal Drugs.
    Craik VB; Johnson AD; Lohse MB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
    Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
    J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.
    Fleischhacker M; Radecke C; Schulz B; Ruhnke M
    Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):127-31. PubMed ID: 18057972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
    Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
    Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients.
    Sharifynia S; Rezaie S; Mohamadnia A; Mortezaee V; Hadian A; Seyedmousavi S
    Med Mycol; 2019 Jan; 57(1):127-131. PubMed ID: 29618069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
    Rueda C; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance to echinocandins in Candida albicans: case report and review.
    Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
    J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.
    Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
    Arendrup MC; Garcia-Effron G; Buzina W; Mortensen KL; Reiter N; Lundin C; Jensen HE; Lass-Flörl C; Perlin DS; Bruun B
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1185-93. PubMed ID: 19104024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of caspofungin with human polymorphonuclear granulocytes for killing Candida albicans.
    Tullio V; Mandras N; Scalas D; Allizond V; Banche G; Roana J; Greco D; Castagno F; Cuffini AM; Carlone NA
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3964-6. PubMed ID: 20585121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
    Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
    Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
    J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance.
    Silver PM; Oliver BG; White TC
    Med Mycol; 2008 May; 46(3):231-9. PubMed ID: 18404551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.